Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BoNT-A in Temporomandibular Myofascial Pain
NCT07847541Phase 2Recruiting
- Sponsor
- Riphah International University
- Start
- Aug 2026
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in temporomandibular disorder (TMD), sponsored by Riphah International University. Started Aug 2026; status: recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
temporomandibular disorder (TMD)
Beyond the preview
Go deeper on NCT07847541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07847541.